Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle - Wikidata - wikimedia - TriplyDB

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

http://www.wikidata.org/entity/Q35133923

about

Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1 Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor Urocortin ameliorates diabetic nephropathy in obese db/db mice Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent islets Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus.Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis.The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment.Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades.CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells.Urocortin 3 activates AMPK and AKT pathways and enhances glucose disposal in rat skeletal muscle.Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet.Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit.Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle.cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products Cluster analysis reveals differential transcript profiles associated with resistance training-induced human skeletal muscle hypertrophy.One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistance Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes.The corticotropin releasing factor system in the kidney: perspectives for novel therapeutic intervention in nephrology.Renin inhibition in the treatment of diabetic kidney disease.Activation of corticotropin-releasing factor receptor 2 inhibits the growth of human small cell lung carcinoma cells.The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.Musclin inhibits insulin activation of Akt/protein kinase B in rat skeletal muscle.Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/GSK-3β signaling pathway.The relationship of urocortin-2 with insulin resistance patients having PCOS.Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2.

P2860

Q24308848-DF8FFD73-1282-4F6E-9FF2-81A0020DFF0A Q28296331-A8A98C33-B8D2-4E7D-A787-782879EEBFEF Q28573393-61D178C5-6BC5-4F16-8B4F-CB3B55F87586 Q28577670-D44304F9-584E-483E-B893-6A9A11889D1F Q28579641-71A0E243-DB36-4D19-ACB1-3B1E05BB9466 Q30300188-A2BA1E06-D166-4CB3-BD53-33BC15FD9096 Q30422882-67DF5B80-596F-4DD7-B30F-A6C3A00B9342 Q30495006-F987AA61-32AC-4A97-AA8B-CB19F99858A0 Q33607272-C954BA2E-1DB2-411D-8B1D-BD14E78A932F Q33643265-AF88B3BF-DFA4-49BC-BB69-4587E14F02CF Q34223469-DC8B829F-23B1-4F62-B2E3-53581A12BE7D Q34312180-06FF4935-A061-4873-B7AD-B75511288DEF Q35146002-3EF29E2F-58BC-463F-A135-1CF59A84FCEB Q35986036-FED8882A-4FB2-4353-8161-C0E177C9A119 Q36073670-0071CE8A-965D-4360-B67A-652ECC1FBE2F Q36114861-36384AE2-5A4B-4817-86A8-F4A2227D5DE6 Q36699526-762B9674-FEA5-4ABB-90D7-37AFBC86C277 Q36923977-2795DDA1-2EFD-41EE-A95E-765445C1ED80 Q37277047-EB54A236-C407-45A3-B157-75E6D5E8C59F Q37369171-1297A8F4-C437-42A0-8332-03958D954A16 Q38012654-5D575E54-DD16-4D27-87FC-B45FB3034070 Q38075571-93E8A5D5-A397-4C12-8DC0-DA807D2101A5 Q39766058-20C8B646-90A7-4627-BEFE-80740866F598 Q42796049-BAEC8791-77F9-456F-B44C-05E81CB830CF Q46556309-5C0C55D3-45A5-422F-941E-5DBDF851C02C Q48866411-7929F1EF-5C6E-44D7-9992-9F86B6CA5685 Q51276343-356D06FB-6473-411E-AEE2-1F905F335A49 Q53087392-031034ED-CCC1-48AB-80E8-0F0A821EFEAA

P2860

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

http://www.wikidata.org/entity/Q35133923

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

@ast

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

@en

type

label

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

@ast

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

@en

prefLabel

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

@ast

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

@en

P1433

Q35133923-B711397B-CDDF-477C-86AA-84E5AF0623D6

P1476

Q35133923-F357BEED-82D2-4973-ACF0-E1D60C19103F

P2093

Q35133923-077F044E-5AFA-4606-B0E8-BF0184BCDA1B

Q35133923-18E77B0B-2F4A-4F69-9B3E-51BD5457A4AB

Q35133923-1A3103A7-5ABE-40E6-9EF9-C5177D5EB384

Q35133923-2DA0C03E-403A-4F5D-B0A9-9D8A52401F04

Q35133923-3C1FA13F-10F2-4BA6-B903-3A75EE0543B2

Q35133923-3E86B40A-54FB-4F5D-880D-834A1FCA5EDE

Q35133923-3F244818-583B-43DF-BFBE-E3397A57E788

Q35133923-68E98294-67A1-412B-80AD-FC8150470408

Q35133923-6C7DC78E-AE12-4B61-B66F-2858E3DA63F3

Q35133923-81314277-46CF-4450-B6FF-6C3123C2D5A8

P2860

Q35133923-05B9F945-B2FF-4687-9075-AA4CDDF9E5B3

Q35133923-0AD3FC90-1E27-4497-870F-B76A77148261

Q35133923-2BD30C7F-EB5A-4004-84DE-87743BDA3902

Q35133923-3461C80D-0B68-4BF3-89CA-E67778ED735C

Q35133923-3F0F1197-2D34-4D43-A74D-EC7EE698A6E0

Q35133923-40594E12-A701-4D15-A0F5-920432921545

Q35133923-4FE28B18-0B7D-4201-B9E0-1AC66C4E6356

Q35133923-5B49DCC8-1A4D-4EF4-9955-A7D85D2EB118

Q35133923-61625E8D-7B54-4AAF-B06D-3B13E12496E9

Q35133923-70BC2990-444C-4B95-890E-3EE33ED955AC

P304

Q35133923-AF9A21B4-BDC9-4A78-A032-9E9CE2622345

P31

Q35133923-38B3CDFB-2FC9-4443-8F23-A4AAF34C06B6

P356

Q35133923-EB9398BC-6F39-473E-A703-63684D2D571B

P407

Q35133923-CA791C2E-13CF-4AF5-A8C6-BF4D2B1E0FD2

P433

Q35133923-3CFB8ECE-CE22-4CBF-8AEA-AC1D3FA35292

P478

Q35133923-36411810-AA97-4524-86D2-EC1D9ADF1959

P50

Q35133923-2FB68F64-8E81-4849-A17A-CCCF5EDF9D96

Q35133923-D8CA8921-F97D-404A-81EC-2639DADEF7F5

P577

Q35133923-A3C85964-3D6F-47D1-BE4C-13327E4C3900

P5875

Q35133923-8F5DB2D0-4C84-4DE6-ACA8-81DB6A811D51

P698

Q35133923-445FD516-0D1F-4350-AAEB-54731335B6EF

P932

Q35133923-BC2348F6-6E5F-4BD4-A190-488B61FAE439

P356

PNAS.0607337103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle

@en

P2093

Alon Chen

http://www.w3.org/2001/XMLSchema#string

Bhawanjit Brar

http://www.w3.org/2001/XMLSchema#string

Cheol Soo Choi

http://www.w3.org/2001/XMLSchema#string

Chien Li

http://www.w3.org/2001/XMLSchema#string

Cindy Donaldson

http://www.w3.org/2001/XMLSchema#string

David Rousso

http://www.w3.org/2001/XMLSchema#string

Joan Vaughan

http://www.w3.org/2001/XMLSchema#string

Kuo-Fen Lee

http://www.w3.org/2001/XMLSchema#string

Pauline Jamieson

http://www.w3.org/2001/XMLSchema#string

Sean M Smith

http://www.w3.org/2001/XMLSchema#string

P2860

The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids

Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

PPARs and the complex journey to obesity

Cellular mechanisms of insulin resistance

Obesity and the regulation of energy balance

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

P304

16580-16585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0607337103

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Gerald I. Shulman

P577

2006-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6744486

http://www.w3.org/2001/XMLSchema#string

P698

17050686

http://www.w3.org/2001/XMLSchema#string

P932

1637624

http://www.w3.org/2001/XMLSchema#string